A Multivalent Peptoid Conjugate Modulates Androgen Receptor Transcriptional Activity to Inhibit Therapy-resistant Prostate Cancer.
Habault J, Schneider JA, Ha S, Ruoff R, Pereira LD, Puccini J, Ranieri M, Ayasun R, Deng J, Kasper AC, Bar-Sagi D, Wong KK, Zoubeidi A, Claessens F, Wise DR, Logan SK, Kirshenbaum K, Garabedian MJ.
Habault J, et al. Among authors: puccini j.
Mol Cancer Ther. 2023 Oct 2;22(10):1166-1181. doi: 10.1158/1535-7163.MCT-23-0196.
Mol Cancer Ther. 2023.
PMID: 37486978
Free PMC article.